Last reviewed · How we verify

NCT04092465: SRaIT

Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)

Completed Last updated 17 September 2019
What this trial tests

trial testing Pulmonary parenchyma resection, lobectomy, pneumonectomy, sleeve lobectomy, extended lobectomy/pneumonectomy in Patient Outcome Assessment in 42 participants. Completed in 31 August 2019.

Timeline
30 September 2011
Primary endpoint
31 August 2019
31 August 2019

Quick facts

Lead sponsorAHEPA University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment42
Start date30 September 2011
Primary completion31 August 2019
Estimated completion31 August 2019

Drugs / interventions tested

Conditions studied

Sponsor

AHEPA University Hospital

Who can join

Eligibility, any sex, with Patient Outcome Assessment or Morbidity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgery still remains the main treatment option for Non-Small Cell Lung Cancer (NSCLC) which is limited within the lung parenchyma and possibly invades the intrapulmonary or hilar nodes. The role of surgery in locally advanced NSCLC with the form of invasion of adjacent strictures or mediastinal nodes is a 30-year point of discussion and debate among thoracic surgeons, clinical and radiation oncologists, chest physicians and other related specialties. Despite the continuous debate the management of locally advanced NSCLC varies between different countries and different institutions.We try to investigate the short and long term outcomes of surgery after induction treatment performed for locally advanced NSCLC.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Patient Outcome Assessment

Currently open trials in the same condition.

Other AHEPA University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04092465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing